Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The poultry medicine/pharmaceuticals market is projected to reach USD 6.68 billion by 2029 from USD 5.01 billion in 2024, at a CAGR of 5.9% during the forecast period. The increasing consumption of poultry and its products from the developing countries is mainly responsible for the growth of poultry medicine/pharmaceuticals market as it results in increased poultry farming practices. The rise in illnesses in poultry, especially Newcastle disease and Coccidiosis, leads to the need for vaccines, antibiotics, and immune boosters. Also, the growing attention towards food safety and the reduction of antibiotics, has made many farms to resort to alternative therapies such as probiotics and more effective vaccines. Furthermore, the growing rates of poultry production amongst developing countries increases the demand for efficacious medicine/pharmaceuticals, which contributes to the sustainable, safe and productive poultry keeping.
“By animal type, chickens segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on animal type, the chickens segment is expected to hold the largest market share in the poultry medicine/pharmaceuticals market. Owing to high domestic poultry consumption of protein sources like chicken meat and eggs. This increase in demand has contributed change in age to the poultry farming especially in developing areas with an increase in the production of chickens. Chickens are also commonly affected by several diseases; Newcastle disease, Infectious Bronchitis and Coccidiosis, which explains the use of vaccines, antibiotics and probiotics to enhance the health and productivity of the flocks Several factors attributed to increasing food production also explain the need for higher standards biologically and on farm bio-security interventions. Innovations in vaccine delivery methods such as in ovo vaccination have enhanced the efficiency and effectiveness of immunization on a large scale providing more avenues for consumption of poultry medicine/pharmaceuticals.
“By product, vaccine segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on product, the largest share of this market is vaccines since they are critical in the prevention of infectious diseases which can rapidly spread through large flocks, like Newcastle disease, Infectious Bronchitis, and Avian Influenza. Effective vaccination of a poultry flock ensures health, productivity, and minimization of losses due to eventual flock culling order by the veterinary authority. Regulatory pressure to lower the use of antibiotics makes vaccines a preferred choice in the management of diseases as they prevent infections without adding to antimicrobial resistance. Technology advancement, such as ovo vaccination, allows for efficient mass immunization; thus, vaccine administration has become practical and scalable to large poultry farms. In the context of disease prevention and sustainable farming practices, vaccines have cemented their position as the largest segment in the poultry medicine/pharmaceuticals market.
“By disease indication, newcastle disease segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on disease indication, the largest share of this market is newcastle disease since the disease affects the poultry worldwide and severely impacts poultry farmers economically. High mortality rates and losses in productivity due to outbreak required vaccination programmes; therefore, vaccines against Newcastle disease are indispensable in poultry health management. Second-generation recombinant and thermostable vaccines have helped increase the ease of use and thus their usage in countries with intensive poultry farming. The continued emphasis on disease prevention and government containment programs have made Newcastle Disease the largest category in the poultry medicine/pharmaceuticals market.
“By route of administration, oral segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on route of administration, The oral route of administration in poultry medicine/pharmaceuticals is efficient and convenient in the medication of large flocks in comparison to the other routes as it delivers medication through either water or feed, thereby getting an equal amount of dose delivery to all birds without time-consuming and stressful individual birds' handling. The oral route is most suited for antibiotics, vaccines, probiotics, and vitamins and therefore used in a very diversified preventive and therapeutic mode of application. Labor cost-cutting, simplification in dosing, and accommodation in large-scale poultry systems where quick effective management of disease is important make this route highly acceptable. Given the practicality and economies of scale involved in oral delivery, this mode forms the mainstay in the poultry farming business and commands the market for medicine/pharmaceuticals.
“By region, North America region is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
The poultry medicine/pharmaceuticals market is dominated by North America as a result of advanced poultry farming systems prevalent in the region, high poultry products intake, and greater concern for biosecurity and disease control. The region is characterized by existing legislation that encourages responsible antibiotic use and as a consequence drive producers to vaccines and other health solutions in the production of food. Continuous investments in research and development as well as modern technologies put in place for the management and therapy of diseases further promotes upward movement of this market. On top of that, due to the fact that there is a growing need for sustainable as well as high-yield systems of poultry rearing, the production of medicines that assist in maintaining flocks health and productivity has increased in the region thereby further entrenching North America’s market leader position.
A breakdown of the primary participants (supply-side) for the poultry medicine/pharmaceuticals market referred to for this report is provided below:
Research Coverage:
The report analyzes the poultry medicine/pharmaceuticals market and aims at estimating the market size and future growth potential of this market based on various segments such as animal type, product, route of administration and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall poultry medicine/pharmaceuticals market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
“By animal type, chickens segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on animal type, the chickens segment is expected to hold the largest market share in the poultry medicine/pharmaceuticals market. Owing to high domestic poultry consumption of protein sources like chicken meat and eggs. This increase in demand has contributed change in age to the poultry farming especially in developing areas with an increase in the production of chickens. Chickens are also commonly affected by several diseases; Newcastle disease, Infectious Bronchitis and Coccidiosis, which explains the use of vaccines, antibiotics and probiotics to enhance the health and productivity of the flocks Several factors attributed to increasing food production also explain the need for higher standards biologically and on farm bio-security interventions. Innovations in vaccine delivery methods such as in ovo vaccination have enhanced the efficiency and effectiveness of immunization on a large scale providing more avenues for consumption of poultry medicine/pharmaceuticals.
“By product, vaccine segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on product, the largest share of this market is vaccines since they are critical in the prevention of infectious diseases which can rapidly spread through large flocks, like Newcastle disease, Infectious Bronchitis, and Avian Influenza. Effective vaccination of a poultry flock ensures health, productivity, and minimization of losses due to eventual flock culling order by the veterinary authority. Regulatory pressure to lower the use of antibiotics makes vaccines a preferred choice in the management of diseases as they prevent infections without adding to antimicrobial resistance. Technology advancement, such as ovo vaccination, allows for efficient mass immunization; thus, vaccine administration has become practical and scalable to large poultry farms. In the context of disease prevention and sustainable farming practices, vaccines have cemented their position as the largest segment in the poultry medicine/pharmaceuticals market.
“By disease indication, newcastle disease segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on disease indication, the largest share of this market is newcastle disease since the disease affects the poultry worldwide and severely impacts poultry farmers economically. High mortality rates and losses in productivity due to outbreak required vaccination programmes; therefore, vaccines against Newcastle disease are indispensable in poultry health management. Second-generation recombinant and thermostable vaccines have helped increase the ease of use and thus their usage in countries with intensive poultry farming. The continued emphasis on disease prevention and government containment programs have made Newcastle Disease the largest category in the poultry medicine/pharmaceuticals market.
“By route of administration, oral segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
Based on route of administration, The oral route of administration in poultry medicine/pharmaceuticals is efficient and convenient in the medication of large flocks in comparison to the other routes as it delivers medication through either water or feed, thereby getting an equal amount of dose delivery to all birds without time-consuming and stressful individual birds' handling. The oral route is most suited for antibiotics, vaccines, probiotics, and vitamins and therefore used in a very diversified preventive and therapeutic mode of application. Labor cost-cutting, simplification in dosing, and accommodation in large-scale poultry systems where quick effective management of disease is important make this route highly acceptable. Given the practicality and economies of scale involved in oral delivery, this mode forms the mainstay in the poultry farming business and commands the market for medicine/pharmaceuticals.
“By region, North America region is expected to have the largest market share in the poultry medicine/pharmaceuticals market.”
The poultry medicine/pharmaceuticals market is dominated by North America as a result of advanced poultry farming systems prevalent in the region, high poultry products intake, and greater concern for biosecurity and disease control. The region is characterized by existing legislation that encourages responsible antibiotic use and as a consequence drive producers to vaccines and other health solutions in the production of food. Continuous investments in research and development as well as modern technologies put in place for the management and therapy of diseases further promotes upward movement of this market. On top of that, due to the fact that there is a growing need for sustainable as well as high-yield systems of poultry rearing, the production of medicines that assist in maintaining flocks health and productivity has increased in the region thereby further entrenching North America’s market leader position.
A breakdown of the primary participants (supply-side) for the poultry medicine/pharmaceuticals market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
- By Designation: C-level–20%, Director Level–35%, and Others–45%
- By Region: North America–27%, Europe–25%, Asia Pacific–30%, ROW-18%
Research Coverage:
The report analyzes the poultry medicine/pharmaceuticals market and aims at estimating the market size and future growth potential of this market based on various segments such as animal type, product, route of administration and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall poultry medicine/pharmaceuticals market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (increasing poultry consumption, growing incidence of poultry diseases, advances in poultry medicine/pharmaceuticals, initiatives by government agencies and animal associations), restraints (high cost of vaccines development, antibiotic resistance concerns), opportunities (growth in emerging markets, industrialization of poultry farming), challenges (regulatory compliance)
- ZMarket Penetration: It includes extensive information on products offered by the major players in the global the poultry medicine/pharmaceuticals market. The report includes various segments in offering, application, end user and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global poultry medicine/pharmaceuticals market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the poultry medicine/pharmaceuticals market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global poultry medicine/pharmaceuticals market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKETS & REGIONS COVERED
1.3.1 YEARS CONSIDERED
1.3.2 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 POULTRY PHARMACEUTICALS MARKET OVERVIEW
4.2 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT AND COUNTRY (2023)
4.3 POULTRY PHARMACEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 POULTRY PHARMACEUTICALS MARKET, BY REGION (2022?2029)
4.5 POULTRY PHARMACEUTICALS MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing poultry consumption
5.2.1.2 Growing incidence of poultry diseases
5.2.1.3 Advancements in poultry pharmaceuticals
5.2.1.4 Favorable initiatives by government agencies & animal
welfare associations
5.2.2 RESTRAINTS
5.2.2.1 High cost of vaccine development
5.2.2.2 Concerns associated with antibiotic resistance
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of emerging economies
5.2.3.2 Industrialization of poultry farming
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory compliance for poultry pharmaceuticals
5.3 INDUSTRY TRENDS
5.3.1 ANTIBIOTIC-FREE SOLUTIONS
5.3.2 EMERGENCE OF INNOVATIVE VACCINE TECHNOLOGIES
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 mRNA vaccines
5.6.1.2 Nanoparticle drug delivery
5.6.1.3 CRISPR gene editing
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 IoT-enabled health monitoring
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Automated drug delivery systems
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY LANDSCAPE
5.8.1 REGULATORY ANALYSIS
5.8.1.1 US
5.8.1.2 Europe
5.8.1.3 Asia Pacific
5.8.1.4 Latin America
5.8.1.5 Middle East & Africa
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.8.2.1 North America
5.8.2.2 Europe
5.8.2.3 Rest of the World
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR POULTRY PHARMACEUTICALS
5.10 TRADE ANALYSIS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICALS, BY REGION (2022?2024)
5.11.2 AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023)
5.12 KEY CONFERENCES AND EVENTS, 2024?2025
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS AND END-USER EXPECTATIONS
5.14.1 UNMET NEEDS
5.14.2 END-USER EXPECTATIONS
5.15 ECOSYSTEM MARKET ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY 1: MARKET DEVELOPMENT IN NIGER DELTA (MADE)
5.16.2 CASE STUDY 2: JOURNEY OF TRIBAL WOMEN
5.16.3 CASE STUDY 3: PROBLEMS & PROSPECTS OF POULTRY FARMING IN CHITTOOR, ANDHRA PRADESH
5.17 ADJACENT MARKET ANALYSIS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI/GENAI ON POULTRY PHARMACEUTICALS MARKET
6 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE
6.1 INTRODUCTION
6.2 CHICKEN
6.2.1 BROILER
6.2.1.1 Specifically bred for high meat yield to drive market
6.2.2 LAYER
6.2.2.1 Growing demand for eggs to fuel market
6.3 TURKEY
6.3.1 CONSUMER PREFERENCE FOR ORGANIC TURKEY BY-PRODUCTS TO
DRIVE MARKET
6.4 DUCK
6.4.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED VACCINES FOR
DVH TO FUEL UPTAKE
6.5 OTHER POULTRY
7 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 DRUGS
7.2.1 ANTIBIOTICS
7.2.1.1 Most widely used drug in poultry management to drive market
7.2.2 ANTIPARASITICS
7.2.2.1 Ability to combat against coccidiosis and ectoparasites to
boost demand
7.2.3 ANTISEPTICS
7.2.3.1 Maintainance of biosecurity through infection reduction to
fuel uptake
7.2.4 NUTRITIONALS
7.2.4.1 Optimization of poultry health with enhanced productivity to
support market growth
7.2.5 OTHER DRUGS
7.3 VACCINES
7.3.1 LIVE-ATTENUATED VACCINES
7.3.1.1 Cost-efficiency and high efficacy benefits to fuel uptake
7.3.2 INACTIVATED VACCINES
7.3.2.1 Pathogen carriers with high stability to drive market
7.3.3 RECOMBINANT VACCINES
7.3.3.1 Ability to combat several avian diseases to boost demand
7.3.4 OTHER VACCINES
7.4 FEED ADDITIVES
7.4.1 ADDITIONAL INCORPORATION TO DIETS FOR ENHANCED BENEFITS
TO SUPPORT MARKET GROWTH
8 POULTRY PHARMACEUTICALS MARKET, BY DISEASE TYPE
8.1 INTRODUCTION
8.2 NEWCASTLE DISEASE
8.2.1 INNOVATIONS IN NEXT-GEN VACCINES TO PROPEL MARKET
8.3 INFECTIOUS BRONCHITIS
8.3.1 HIGH MORTALITY CASES TO BOOST DEMAND
8.4 INFECTIOUS BURSAL DISEASE
8.4.1 GROWING DEMAND FOR MULTIVALENT VACCINES TO FUEL MARKET
8.5 COCCIDIOSIS
8.5.1 DEVELOPMENT OF ANTI-COCCIDIAL DRUGS TO FUEL UPTAKE
8.6 SALMONELLA
8.6.1 INCREASING INCIDENCE OF SALMONELLA OUTBREAKS TO DRIVE MARKET
8.7 MAREK’S DISEASE
8.7.1 GROWING FOCUS ON ENSURING FLOCK PRODUCTIVITY TO SUPPORT MARKET
8.8 OTHER DISEASES
9 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION
9.1 INTRODUCTION
9.2 ORAL ROUTE OF ADMINISTRATION
9.2.1 HIGH UPTAKE OF ANTIBIOTICS DUE TO SCALABILITY AND COST-EFFICIENCY TO DRIVE MARKET
9.3 INJECTABLE ROUTE OF ADMINISTRATION
9.3.1 RAPID TREATMENT RESPONSE TO FUEL MARKET
9.4 TOPICAL ROUTE OF ADMINISTRATION
9.4.1 UPTAKE OF ANTIPARASITIC TREATMENT TO SUPPORT MARKET GROWTH
9.5 OTHER ROUTES
10 POULTRY PHARMACEUTICALS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Stringent regulatory protocols for disease prevention to drive market
10.2.3 CANADA
10.2.3.1 Growing focus on animal health to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Growing awareness of poultry health issues in Germany
10.3.3 UK
10.3.3.1 Growing focus on antibiotic-free poultry to boost demand
10.3.4 FRANCE
10.3.4.1 Avian influenza outbreaks and disease prevention strategies to
fuel market growth
10.3.5 SPAIN
10.3.5.1 Increased poultry production and export to drive market
10.3.6 ITALY
10.3.6.1 Rising poultry trade and biosecurity measures to drive market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Focus on biosecurity and innovative pharmaceutical products to drive market
10.4.3 CHINA
10.4.3.1 Increasing incidence of avian influenza to boost demand
10.4.4 INDIA
10.4.4.1 Rapid expansion of poultry farming to fuel uptake
10.4.5 AUSTRALIA
10.4.5.1 Growing focus on advanced pharmaceuticals to support market
10.4.6 SOUTH KOREA
10.4.6.1 Frequent outbreak of coccidiosis to support market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Surge in poultry export to fuel uptake
10.5.3 MEXICO
10.5.3.1 Increasing investments in broiler genetics to propel market
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Expanding poultry sector to fuel uptake
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POULTRY PHARMACEUTICALS MARKET
11.3 REVENUE ANALYSIS, 2019?2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Animal type footprint
11.5.5.4 Product footprint
11.5.5.5 Disease indication footprint
11.5.5.6 Route of administration footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MERCK ANIMAL HEALTH (SUBSIDIARY OF MERCK & CO., INC.)
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 MnM view
12.1.1.3.1 Key strengths
12.1.1.3.2 Strategic choices
12.1.1.3.3 Weaknesses & competitive threats
12.1.2 ELANCO
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.3.2 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product approvals
12.1.3.3.2 Deals
12.1.3.3.3 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 CEVA SANTE ANIMALE
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Key strengths
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses & competitive threats
12.1.5 ZOETIS SERVICES LLC
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.3.2 Expansions
12.1.5.3.3 Other developments
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 VIRBAC
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 PHIBRO ANIMAL HEALTH CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 HESTER BIOSCIENCES LIMITED
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 MEIJI ANIMAL HEALTH CO, LTD. (SUBSIDIARY OF K.M BIOLOGICS CO. LTD.)
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 VENKY’S INDIA
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 BIMEDA CORPORATE
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 CALIER
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 HIPRA
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 VETANCO
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 VAXXINOVA INTERNATIONAL BV
12.1.15.1 Business overview
12.1.15.2 Products offered
12.1.16 BIOVAC GROUP
12.1.16.1 Business overview
12.1.16.2 Products offered
12.1.17 KEMIN INDUSTRIES, INC.
12.1.17.1 Business overview
12.1.17.2 Products offered
12.1.18 Î.L.KAR.-AGROZOOVET-SERVICE
12.1.18.1 Business overview
12.1.18.2 Products offered
12.1.19 INDOVAX
12.1.19.1 Business overview
12.1.19.2 Products offered
12.1.20 AVIMEX
12.1.20.1 Business overview
12.1.20.2 Products offered
12.2 OTHER PLAYERS
12.2.1 SYNTHESE ELEVAGE
12.2.2 PROVET PHARMA PRIVATE LIMITED
12.2.3 HUVEPHARMA
12.2.4 ROMVAC COMPANY S.A.
12.2.5 VMN PHARMACEUTICALS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 POULTRY PHARMACEUTICALS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 3 IMPACT ANALYSIS OF PORTER’S FIVE FORCES
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LIST OF PATENTS IN POULTRY PHARMACEUTICALS MARKET, 2022–2024
TABLE 8 IMPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 10 AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICAL PRODUCTS,
BY REGION (2022?2024)
TABLE 11 AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023) (USD)
TABLE 12 POULTRY PHARMACEUTICALS MARKET: KEY CONFERENCES & EVENTS,
2024-2025
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DRUGS,
VACCINES, AND FEED ADDITIVES
TABLE 14 KEY BUYING CRITERIA FOR DRUGS, VACCINES, AND FEED ADDITIVES
TABLE 15 END-USER EXPECTATIONS FOR DRUGS, VACCINES, AND FEED ADDITIVES
TABLE 16 POULTRY PHARMACEUTICALS MARKET: ECOSYSTEM ANALYSIS
TABLE 17 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 18 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 19 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
TABLE 20 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 21 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 22 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 23 BROILER PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 24 BROILER PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 25 LAYER PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 26 LAYER PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 27 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 28 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 29 DUCK PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 30 DUCK PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 31 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 32 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 33 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 34 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 35 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 36 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 37 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION,
2019–2022 (USD MILLION)
TABLE 38 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION,
2023–2029 (USD MILLION)
TABLE 39 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION,
2019–2022 (USD MILLION)
TABLE 40 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION,
2023–2029 (USD MILLION)
TABLE 41 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION,
2019–2022 (USD MILLION)
TABLE 42 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION,
2023–2029 (USD MILLION)
TABLE 43 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION,
2019–2022 (USD MILLION)
TABLE 44 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION,
2023–2029 (USD MILLION)
TABLE 45 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION,
2019–2022 (USD MILLION)
TABLE 46 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION,
2023–2029 (USD MILLION)
TABLE 47 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION,
2019–2022 (USD MILLION)
TABLE 48 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION,
2023–2029 (USD MILLION)
TABLE 49 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 50 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 51 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION,
2019–2022 (USD MILLION)
TABLE 52 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION,
2023–2029 (USD MILLION)
TABLE 53 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES,
BY REGION, 2019–2022 (USD MILLION)
TABLE 54 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES,
BY REGION, 2023–2029 (USD MILLION)
TABLE 55 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2019–2022 (USD MILLION)
TABLE 56 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2023–2029 (USD MILLION)
TABLE 57 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2019–2022 (USD MILLION)
TABLE 58 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2023–2029 (USD MILLION)
TABLE 59 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION,
2019–2022 (USD MILLION)
TABLE 60 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION,
2023–2029 (USD MILLION)
TABLE 61 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION,
2019–2022 (USD MILLION)
TABLE 62 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION,
2023–2029 (USD MILLION)
TABLE 63 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 64 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 65 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2019–2022 (USD MILLION)
TABLE 66 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2023–2029 (USD MILLION)
TABLE 67 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2019–2022 (USD MILLION)
TABLE 68 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2023–2029 (USD MILLION)
TABLE 69 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE,
BY REGION, 2019–2022 (USD MILLION)
TABLE 70 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE,
BY REGION, 2023–2029 (USD MILLION)
TABLE 71 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION,
2019–2022 (USD MILLION)
TABLE 72 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION,
2023–2029 (USD MILLION)
TABLE 73 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION,
2019–2022 (USD MILLION)
TABLE 74 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION,
2023–2029 (USD MILLION)
TABLE 75 POULTRY PHARMACEUTICALS MARKET FOR MAREK’S DISEASE, BY REGION, 2019–2022 (USD MILLION)
TABLE 76 POULTRY PHARMACEUTICALS MARKET FOR MAREK’S DISEASE, BY REGION, 2023–2029 (USD MILLION)
TABLE 77 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION,
2019–2022 (USD MILLION)
TABLE 78 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION,
2023–2029 (USD MILLION)
TABLE 79 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION,
2019–2022 (USD MILLION)
TABLE 80 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION,
2023–2029 (USD MILLION)
TABLE 81 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 82 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 83 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 84 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 85 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 86 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 87 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 88 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 89 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 90 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 92 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 94 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 96 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 98 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 99 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 100 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 102 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 103 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 104 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 105 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 106 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 107 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 108 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 109 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2019–2022 (USD MILLION)
TABLE 110 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2023–2029 (USD MILLION)
TABLE 111 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 112 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 113 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2019–2022 (USD MILLION)
TABLE 114 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2023–2029 (USD MILLION)
TABLE 115 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 116 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 117 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 118 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 119 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 120 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 121 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 122 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 123 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 124 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 125 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 126 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 127 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 128 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 129 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 130 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 131 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 132 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 133 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 134 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 135 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 136 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 137 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 138 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 139 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 140 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 141 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 142 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 143 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 144 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 145 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 146 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 147 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 148 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 149 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 150 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 151 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 152 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 153 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2019–2022 (USD MILLION)
TABLE 154 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2023–2029 (USD MILLION)
TABLE 155 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 156 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 157 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2019–2022 (USD MILLION)
TABLE 158 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2023–2029 (USD MILLION)
TABLE 159 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 160 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 161 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 162 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 163 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 164 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 165 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 166 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 167 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
TABLE 168 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 169 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 170 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 171 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 172 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 173 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 174 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 175 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 176 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 177 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 178 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 179 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 180 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 181 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 182 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 183 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 184 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 185 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 186 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 187 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 188 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 189 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 190 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 191 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 192 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 193 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 194 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 195 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 196 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 197 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 198 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 199 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 200 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 201 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 202 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 203 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 204 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 205 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 206 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 207 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 208 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 209 ITALY: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 210 ITALY: CHICEKN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 211 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 212 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 213 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 214 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 215 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 216 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 217 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 218 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 219 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 220 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 221 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 222 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 223 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 224 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 225 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 226 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 227 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 228 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 229 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 230 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 231 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 232 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 233 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 234 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 235 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 236 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 237 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 238 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 239 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 240 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 241 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 242 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 244 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 245 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 246 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 247 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 248 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 249 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 250 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 251 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 252 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 253 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 254 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 255 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 256 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 257 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 258 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 259 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 260 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 261 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 262 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 263 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 264 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 265 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 266 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 267 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 268 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 269 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 270 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 271 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 272 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 273 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 274 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 275 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 276 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 277 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 278 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 279 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 280 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 281 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 282 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 283 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 284 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 285 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 286 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 287 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 288 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 289 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 290 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 291 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 292 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 293 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 294 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 295 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 296 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 297 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 298 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 299 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 300 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 301 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 302 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 303 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 304 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 305 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 306 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 307 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 308 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 309 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 310 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 311 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 312 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 313 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 314 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 315 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 316 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 317 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 318 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 319 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 320 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 327 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 328 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 334 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 335 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 336 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 337 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 338 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 339 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 340 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 341 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 342 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 343 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 344 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 345 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 346 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 347 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 348 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 349 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 350 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 351 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 352 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 353 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 354 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 355 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 356 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 357 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 358 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 359 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 360 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 361 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 362 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 363 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 364 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 365 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 366 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 367 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 368 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 369 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 370 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 371 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 372 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 373 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 374 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 375 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 376 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 377 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 378 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 379 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 380 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 381 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 382 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 383 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 384 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 385 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 386 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 387 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 388 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 389 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 390 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 391 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 392 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 393 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 394 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 395 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 396 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 397 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 398 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 399 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 400 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 401 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 402 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 403 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 404 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 405 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 406 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 407 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 408 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 409 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 410 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 411 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 412 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 413 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 414 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 415 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 416 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 417 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 418 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 419 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 420 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 421 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 422 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 423 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 424 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 425 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 426 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 427 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 428 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 429 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 430 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 431 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 432 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 433 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 434 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 435 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 436 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 437 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 438 POULTRY PHARMACEUTICALS MARKET: DEGREE OF COMPETITION
TABLE 439 POULTRY PHARMACEUTICALS MARKET: REGION FOOTPRINT
TABLE 440 POULTRY PHARMACEUTICALS MARKET: ANIMAL TYPE FOOTPRINT
TABLE 441 POULTRY PHARMACEUTICALS MARKET: PRODUCT FOOTPRINT
TABLE 442 POULTRY PHARMACEUTICALS MARKET: DISEASE INDICATION FOOTPRINT
TABLE 443 POULTRY PHARMACEUTICALS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
TABLE 444 POULTRY PHARMACEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 445 POULTRY PHARMACEUTICALS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 446 POULTRY PHARMACEUTICALS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021?NOVEMBER 2024
TABLE 447 POULTRY PHARMACEUTICALS MARKET: DEALS, JANUARY 2021?NOVEMBER 2024
TABLE 448 POULTRY PHARMACEUTICALS MARKET:
EXPANSIONS, JANUARY 2021?NOVEMBER 2024
TABLE 449 POULTRY PHARMACEUTICALS MARKET:
OTHER DEVELOPMENTS, JANUARY 2021?NOVEMBER 2024
TABLE 450 MERCK ANIMAL HEALTH: COMPANY OVERVIEW
TABLE 451 MERCK ANIMAL HEALTH: PRODUCTS OFFERED
TABLE 452 ELANCO: COMPANY OVERVIEW
TABLE 453 ELANCO: PRODUCTS OFFERED
TABLE 454 ELANCO: DEALS, JANUARY 2021–NOVEMBER 2024
TABLE 455 ELANCO: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
TABLE 456 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
TABLE 457 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
TABLE 458 BOEHRINGER INGELHEIM INTERNATIONAL GMBH:
PRODUCT APPROVALS, JANUARY 2021– NOVEMBER 2024
TABLE 459 BOEHRINGER INGELHEIM INTERNATIONAL GMBH:
DEALS, JANUARY 2021– NOVEMBER 2024
TABLE 460 BOEHRINGER INGELHEIM INTERNATIONAL GMBH:
EXPANSIONS, JANUARY 2021– NOVEMBER 2024
TABLE 461 CEVA SANTE ANIMALE: COMPANY OVERVIEW
TABLE 462 CEVA SANTE ANIMALE: PRODUCTS OFFERED
TABLE 463 ZOETIS SERVICES LLC: COMPANY OVERVIEW
TABLE 464 ZOETIS SERVICES LLC: PRODUCTS OFFERED
TABLE 465 ZOETIS SERVICES LLC: JANUARY 2021–NOVEMBER 2024
TABLE 466 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
TABLE 467 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
TABLE 468 VIRBAC: COMPANY OVERVIEW
TABLE 469 VIRBAC: PRODUCTS OFFERED
TABLE 470 VIRBAC: DEALS, JANUARY 2021– NOVEMBER 2024
TABLE 471 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY OVERVIEW
TABLE 472 PHIBRO ANIMAL HEALTH CORPORATION: PRODUCTS OFFERED
TABLE 473 PHIBRO ANIMAL HEALTH CORPORATION:
DEALS, JANUARY 2021– NOVEMBER 2024
TABLE 474 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW
TABLE 475 HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED
TABLE 476 HESTER BIOSCIENCES LIMITED: DEALS, JANUARY 2021–NOVEMBER 2024
TABLE 477 MEIJI ANIMAL HEALTH CO., LTD.: COMPANY OVERVIEW
TABLE 478 MEIJI ANIMAL HEALTH CO., LTD.: PRODUCTS OFFERED
TABLE 479 VENKY’S INDIA: COMPANY OVERVIEW
TABLE 480 VENKY’S INDIA: PRODUCTS OFFERED
TABLE 481 BIMEDA CORPORATE: COMPANY OVERVIEW
TABLE 482 BIMEDA CORPORATE: PRODUCTS OFFERED
TABLE 483 CALIER: COMPANY OVERVIEW
TABLE 484 CALIER: PRODUCTS OFFERED
TABLE 485 HIPRA: COMPANY OVERVIEW
TABLE 486 HIPRA: PRODUCTS OFFERED
TABLE 487 VETANCO: COMPANY OVERVIEW
TABLE 488 VETANCO: PRODUCTS OFFERED
TABLE 489 VAXXINOVA INTERNATIONAL BV: COMPANY OVERVIEW
TABLE 490 VAXXINOVA INTERNATIONAL BV: PRODUCTS OFFERED
TABLE 491 BIOVAC GROUP: COMPANY OVERVIEW
TABLE 492 BIOVAC GROUP: PRODUCTS OFFERED
TABLE 493 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 494 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED
TABLE 495 Î.L.KAR.-AGROZOOVET-SERVICE: COMPANY OVERVIEW
TABLE 496 Î.L.KAR.-AGROZOOVET-SERVICE: PRODUCTS OFFERED
TABLE 497 INDOVAX: COMPANY OVERVIEW
TABLE 498 INDOVAX: PRODUCTS OFFERED
TABLE 499 AVIMEX: COMPANY OVERVIEW
TABLE 500 AVIMEX: PRODUCTS OFFERED
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKETS & REGIONS COVERED
1.3.1 YEARS CONSIDERED
1.3.2 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 POULTRY PHARMACEUTICALS MARKET OVERVIEW
4.2 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT AND COUNTRY (2023)
4.3 POULTRY PHARMACEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 POULTRY PHARMACEUTICALS MARKET, BY REGION (2022?2029)
4.5 POULTRY PHARMACEUTICALS MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing poultry consumption
5.2.1.2 Growing incidence of poultry diseases
5.2.1.3 Advancements in poultry pharmaceuticals
5.2.1.4 Favorable initiatives by government agencies & animal
welfare associations
5.2.2 RESTRAINTS
5.2.2.1 High cost of vaccine development
5.2.2.2 Concerns associated with antibiotic resistance
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of emerging economies
5.2.3.2 Industrialization of poultry farming
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory compliance for poultry pharmaceuticals
5.3 INDUSTRY TRENDS
5.3.1 ANTIBIOTIC-FREE SOLUTIONS
5.3.2 EMERGENCE OF INNOVATIVE VACCINE TECHNOLOGIES
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 mRNA vaccines
5.6.1.2 Nanoparticle drug delivery
5.6.1.3 CRISPR gene editing
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 IoT-enabled health monitoring
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Automated drug delivery systems
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY LANDSCAPE
5.8.1 REGULATORY ANALYSIS
5.8.1.1 US
5.8.1.2 Europe
5.8.1.3 Asia Pacific
5.8.1.4 Latin America
5.8.1.5 Middle East & Africa
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.8.2.1 North America
5.8.2.2 Europe
5.8.2.3 Rest of the World
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR POULTRY PHARMACEUTICALS
5.10 TRADE ANALYSIS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICALS, BY REGION (2022?2024)
5.11.2 AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023)
5.12 KEY CONFERENCES AND EVENTS, 2024?2025
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS AND END-USER EXPECTATIONS
5.14.1 UNMET NEEDS
5.14.2 END-USER EXPECTATIONS
5.15 ECOSYSTEM MARKET ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 CASE STUDY 1: MARKET DEVELOPMENT IN NIGER DELTA (MADE)
5.16.2 CASE STUDY 2: JOURNEY OF TRIBAL WOMEN
5.16.3 CASE STUDY 3: PROBLEMS & PROSPECTS OF POULTRY FARMING IN CHITTOOR, ANDHRA PRADESH
5.17 ADJACENT MARKET ANALYSIS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI/GENAI ON POULTRY PHARMACEUTICALS MARKET
6 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE
6.1 INTRODUCTION
6.2 CHICKEN
6.2.1 BROILER
6.2.1.1 Specifically bred for high meat yield to drive market
6.2.2 LAYER
6.2.2.1 Growing demand for eggs to fuel market
6.3 TURKEY
6.3.1 CONSUMER PREFERENCE FOR ORGANIC TURKEY BY-PRODUCTS TO
DRIVE MARKET
6.4 DUCK
6.4.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED VACCINES FOR
DVH TO FUEL UPTAKE
6.5 OTHER POULTRY
7 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 DRUGS
7.2.1 ANTIBIOTICS
7.2.1.1 Most widely used drug in poultry management to drive market
7.2.2 ANTIPARASITICS
7.2.2.1 Ability to combat against coccidiosis and ectoparasites to
boost demand
7.2.3 ANTISEPTICS
7.2.3.1 Maintainance of biosecurity through infection reduction to
fuel uptake
7.2.4 NUTRITIONALS
7.2.4.1 Optimization of poultry health with enhanced productivity to
support market growth
7.2.5 OTHER DRUGS
7.3 VACCINES
7.3.1 LIVE-ATTENUATED VACCINES
7.3.1.1 Cost-efficiency and high efficacy benefits to fuel uptake
7.3.2 INACTIVATED VACCINES
7.3.2.1 Pathogen carriers with high stability to drive market
7.3.3 RECOMBINANT VACCINES
7.3.3.1 Ability to combat several avian diseases to boost demand
7.3.4 OTHER VACCINES
7.4 FEED ADDITIVES
7.4.1 ADDITIONAL INCORPORATION TO DIETS FOR ENHANCED BENEFITS
TO SUPPORT MARKET GROWTH
8 POULTRY PHARMACEUTICALS MARKET, BY DISEASE TYPE
8.1 INTRODUCTION
8.2 NEWCASTLE DISEASE
8.2.1 INNOVATIONS IN NEXT-GEN VACCINES TO PROPEL MARKET
8.3 INFECTIOUS BRONCHITIS
8.3.1 HIGH MORTALITY CASES TO BOOST DEMAND
8.4 INFECTIOUS BURSAL DISEASE
8.4.1 GROWING DEMAND FOR MULTIVALENT VACCINES TO FUEL MARKET
8.5 COCCIDIOSIS
8.5.1 DEVELOPMENT OF ANTI-COCCIDIAL DRUGS TO FUEL UPTAKE
8.6 SALMONELLA
8.6.1 INCREASING INCIDENCE OF SALMONELLA OUTBREAKS TO DRIVE MARKET
8.7 MAREK’S DISEASE
8.7.1 GROWING FOCUS ON ENSURING FLOCK PRODUCTIVITY TO SUPPORT MARKET
8.8 OTHER DISEASES
9 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION
9.1 INTRODUCTION
9.2 ORAL ROUTE OF ADMINISTRATION
9.2.1 HIGH UPTAKE OF ANTIBIOTICS DUE TO SCALABILITY AND COST-EFFICIENCY TO DRIVE MARKET
9.3 INJECTABLE ROUTE OF ADMINISTRATION
9.3.1 RAPID TREATMENT RESPONSE TO FUEL MARKET
9.4 TOPICAL ROUTE OF ADMINISTRATION
9.4.1 UPTAKE OF ANTIPARASITIC TREATMENT TO SUPPORT MARKET GROWTH
9.5 OTHER ROUTES
10 POULTRY PHARMACEUTICALS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Stringent regulatory protocols for disease prevention to drive market
10.2.3 CANADA
10.2.3.1 Growing focus on animal health to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Growing awareness of poultry health issues in Germany
10.3.3 UK
10.3.3.1 Growing focus on antibiotic-free poultry to boost demand
10.3.4 FRANCE
10.3.4.1 Avian influenza outbreaks and disease prevention strategies to
fuel market growth
10.3.5 SPAIN
10.3.5.1 Increased poultry production and export to drive market
10.3.6 ITALY
10.3.6.1 Rising poultry trade and biosecurity measures to drive market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Focus on biosecurity and innovative pharmaceutical products to drive market
10.4.3 CHINA
10.4.3.1 Increasing incidence of avian influenza to boost demand
10.4.4 INDIA
10.4.4.1 Rapid expansion of poultry farming to fuel uptake
10.4.5 AUSTRALIA
10.4.5.1 Growing focus on advanced pharmaceuticals to support market
10.4.6 SOUTH KOREA
10.4.6.1 Frequent outbreak of coccidiosis to support market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Surge in poultry export to fuel uptake
10.5.3 MEXICO
10.5.3.1 Increasing investments in broiler genetics to propel market
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Expanding poultry sector to fuel uptake
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POULTRY PHARMACEUTICALS MARKET
11.3 REVENUE ANALYSIS, 2019?2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Animal type footprint
11.5.5.4 Product footprint
11.5.5.5 Disease indication footprint
11.5.5.6 Route of administration footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MERCK ANIMAL HEALTH (SUBSIDIARY OF MERCK & CO., INC.)
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 MnM view
12.1.1.3.1 Key strengths
12.1.1.3.2 Strategic choices
12.1.1.3.3 Weaknesses & competitive threats
12.1.2 ELANCO
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.3.2 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product approvals
12.1.3.3.2 Deals
12.1.3.3.3 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 CEVA SANTE ANIMALE
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Key strengths
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses & competitive threats
12.1.5 ZOETIS SERVICES LLC
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.3.2 Expansions
12.1.5.3.3 Other developments
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 VIRBAC
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 PHIBRO ANIMAL HEALTH CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 HESTER BIOSCIENCES LIMITED
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 MEIJI ANIMAL HEALTH CO, LTD. (SUBSIDIARY OF K.M BIOLOGICS CO. LTD.)
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 VENKY’S INDIA
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 BIMEDA CORPORATE
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 CALIER
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 HIPRA
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 VETANCO
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 VAXXINOVA INTERNATIONAL BV
12.1.15.1 Business overview
12.1.15.2 Products offered
12.1.16 BIOVAC GROUP
12.1.16.1 Business overview
12.1.16.2 Products offered
12.1.17 KEMIN INDUSTRIES, INC.
12.1.17.1 Business overview
12.1.17.2 Products offered
12.1.18 Î.L.KAR.-AGROZOOVET-SERVICE
12.1.18.1 Business overview
12.1.18.2 Products offered
12.1.19 INDOVAX
12.1.19.1 Business overview
12.1.19.2 Products offered
12.1.20 AVIMEX
12.1.20.1 Business overview
12.1.20.2 Products offered
12.2 OTHER PLAYERS
12.2.1 SYNTHESE ELEVAGE
12.2.2 PROVET PHARMA PRIVATE LIMITED
12.2.3 HUVEPHARMA
12.2.4 ROMVAC COMPANY S.A.
12.2.5 VMN PHARMACEUTICALS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 POULTRY PHARMACEUTICALS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 3 IMPACT ANALYSIS OF PORTER’S FIVE FORCES
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LIST OF PATENTS IN POULTRY PHARMACEUTICALS MARKET, 2022–2024
TABLE 8 IMPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 10 AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICAL PRODUCTS,
BY REGION (2022?2024)
TABLE 11 AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023) (USD)
TABLE 12 POULTRY PHARMACEUTICALS MARKET: KEY CONFERENCES & EVENTS,
2024-2025
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DRUGS,
VACCINES, AND FEED ADDITIVES
TABLE 14 KEY BUYING CRITERIA FOR DRUGS, VACCINES, AND FEED ADDITIVES
TABLE 15 END-USER EXPECTATIONS FOR DRUGS, VACCINES, AND FEED ADDITIVES
TABLE 16 POULTRY PHARMACEUTICALS MARKET: ECOSYSTEM ANALYSIS
TABLE 17 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 18 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 19 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
TABLE 20 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 21 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 22 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 23 BROILER PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 24 BROILER PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 25 LAYER PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 26 LAYER PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 27 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 28 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 29 DUCK PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 30 DUCK PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 31 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 32 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 33 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 34 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 35 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 36 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 37 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION,
2019–2022 (USD MILLION)
TABLE 38 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION,
2023–2029 (USD MILLION)
TABLE 39 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION,
2019–2022 (USD MILLION)
TABLE 40 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION,
2023–2029 (USD MILLION)
TABLE 41 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION,
2019–2022 (USD MILLION)
TABLE 42 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION,
2023–2029 (USD MILLION)
TABLE 43 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION,
2019–2022 (USD MILLION)
TABLE 44 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION,
2023–2029 (USD MILLION)
TABLE 45 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION,
2019–2022 (USD MILLION)
TABLE 46 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION,
2023–2029 (USD MILLION)
TABLE 47 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION,
2019–2022 (USD MILLION)
TABLE 48 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION,
2023–2029 (USD MILLION)
TABLE 49 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 50 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 51 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION,
2019–2022 (USD MILLION)
TABLE 52 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION,
2023–2029 (USD MILLION)
TABLE 53 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES,
BY REGION, 2019–2022 (USD MILLION)
TABLE 54 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES,
BY REGION, 2023–2029 (USD MILLION)
TABLE 55 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2019–2022 (USD MILLION)
TABLE 56 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2023–2029 (USD MILLION)
TABLE 57 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2019–2022 (USD MILLION)
TABLE 58 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2023–2029 (USD MILLION)
TABLE 59 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION,
2019–2022 (USD MILLION)
TABLE 60 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION,
2023–2029 (USD MILLION)
TABLE 61 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION,
2019–2022 (USD MILLION)
TABLE 62 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION,
2023–2029 (USD MILLION)
TABLE 63 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 64 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 65 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2019–2022 (USD MILLION)
TABLE 66 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2023–2029 (USD MILLION)
TABLE 67 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2019–2022 (USD MILLION)
TABLE 68 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2023–2029 (USD MILLION)
TABLE 69 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE,
BY REGION, 2019–2022 (USD MILLION)
TABLE 70 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE,
BY REGION, 2023–2029 (USD MILLION)
TABLE 71 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION,
2019–2022 (USD MILLION)
TABLE 72 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION,
2023–2029 (USD MILLION)
TABLE 73 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION,
2019–2022 (USD MILLION)
TABLE 74 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION,
2023–2029 (USD MILLION)
TABLE 75 POULTRY PHARMACEUTICALS MARKET FOR MAREK’S DISEASE, BY REGION, 2019–2022 (USD MILLION)
TABLE 76 POULTRY PHARMACEUTICALS MARKET FOR MAREK’S DISEASE, BY REGION, 2023–2029 (USD MILLION)
TABLE 77 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION,
2019–2022 (USD MILLION)
TABLE 78 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION,
2023–2029 (USD MILLION)
TABLE 79 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION,
2019–2022 (USD MILLION)
TABLE 80 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION,
2023–2029 (USD MILLION)
TABLE 81 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 82 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 83 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 84 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 85 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 86 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 87 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION,
2019–2022 (USD MILLION)
TABLE 88 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION,
2023–2029 (USD MILLION)
TABLE 89 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 90 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 92 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 94 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 96 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 98 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 99 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 100 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 102 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 103 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 104 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 105 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 106 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 107 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 108 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 109 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2019–2022 (USD MILLION)
TABLE 110 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2023–2029 (USD MILLION)
TABLE 111 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 112 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 113 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2019–2022 (USD MILLION)
TABLE 114 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2023–2029 (USD MILLION)
TABLE 115 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 116 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 117 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 118 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 119 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 120 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 121 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 122 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 123 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 124 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 125 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 126 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 127 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 128 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 129 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 130 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 131 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 132 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 133 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 134 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 135 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 136 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 137 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 138 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 139 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 140 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 141 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 142 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 143 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 144 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 145 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 146 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 147 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 148 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 149 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 150 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 151 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 152 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 153 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2019–2022 (USD MILLION)
TABLE 154 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE,
2023–2029 (USD MILLION)
TABLE 155 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 156 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 157 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2019–2022 (USD MILLION)
TABLE 158 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE
2023–2029 (USD MILLION)
TABLE 159 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 160 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 161 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 162 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 163 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 164 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 165 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 166 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 167 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019–2022 (USD MILLION)
TABLE 168 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023–2029 (USD MILLION)
TABLE 169 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 170 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 171 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 172 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 173 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 174 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 175 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 176 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 177 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 178 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 179 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 180 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 181 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 182 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 183 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 184 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 185 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 186 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 187 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 188 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 189 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 190 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 191 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 192 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 193 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 194 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 195 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 196 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 197 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 198 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 199 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 200 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 201 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 202 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 203 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 204 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 205 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 206 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 207 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 208 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 209 ITALY: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 210 ITALY: CHICEKN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 211 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 212 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 213 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 214 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 215 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 216 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 217 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 218 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 219 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 220 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 221 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 222 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 223 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 224 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 225 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 226 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 227 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 228 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 229 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 230 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 231 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 232 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 233 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 234 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 235 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 236 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 237 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 238 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 239 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 240 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 241 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 242 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 244 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 245 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 246 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 247 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 248 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 249 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 250 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 251 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 252 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 253 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 254 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 255 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 256 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 257 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 258 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 259 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 260 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 261 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 262 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 263 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 264 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 265 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 266 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 267 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 268 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 269 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 270 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 271 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 272 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 273 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 274 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 275 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 276 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 277 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 278 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 279 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 280 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 281 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 282 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 283 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 284 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 285 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 286 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 287 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 288 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 289 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 290 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 291 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 292 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 293 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 294 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 295 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 296 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 297 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 298 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 299 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 300 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 301 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 302 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 303 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 304 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 305 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 306 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 307 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 308 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 309 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 310 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 311 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 312 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 313 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 314 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 315 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 316 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 317 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 318 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 319 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 320 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 327 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 328 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 334 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 335 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2019–2022 (USD MILLION)
TABLE 336 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
TABLE 337 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 338 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 339 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 340 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 341 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 342 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 343 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 344 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 345 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 346 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 347 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 348 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 349 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 350 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 351 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 352 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 353 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 354 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 355 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 356 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 357 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 358 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 359 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 360 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 361 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 362 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 363 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 364 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 365 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 366 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 367 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 368 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 369 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 370 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 371 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2019–2022 (USD MILLION)
TABLE 372 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE,
2023–2029 (USD MILLION)
TABLE 373 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2019–2022 (USD MILLION)
TABLE 374 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE,
2023–2029 (USD MILLION)
TABLE 375 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2019–2022 (USD MILLION)
TABLE 376 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION,
2023–2029 (USD MILLION)
TABLE 377 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 378 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 379 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 380 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 381 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 382 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 383 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 384 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 385 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 386 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 387 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 388 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 389 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 390 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 391 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 392 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 393 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019–2022 (USD MILLION)
TABLE 394 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023–2029 (USD MILLION)
TABLE 395 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 396 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 397 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 398 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 399 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 400 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 401 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 402 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 403 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 404 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 405 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 406 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 407 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 408 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 409 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2019–2022 (USD MILLION)
TABLE 410 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE,
2023–2029 (USD MILLION)
TABLE 411 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2019–2022 (USD MILLION)
TABLE 412 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE,
2023–2029 (USD MILLION)
TABLE 413 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2019–2022 (USD MILLION)
TABLE 414 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
TABLE 415 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 416 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 417 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 418 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 419 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 420 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 421 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 422 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 423 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ANIMAL TYPE, 2019–2022 (USD MILLION)
TABLE 424 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ANIMAL TYPE, 2023–2029 (USD MILLION)
TABLE 425 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET,
BY TYPE, 2019–2022 (USD MILLION)
TABLE 426 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET,
BY TYPE, 2023–2029 (USD MILLION)
TABLE 427 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2019–2022 (USD MILLION)
TABLE 428 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY PRODUCT, 2023–2029 (USD MILLION)
TABLE 429 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR DRUGS, BY TYPE, 2019–2022 (USD MILLION)
TABLE 430 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR DRUGS, BY TYPE, 2023–2029 (USD MILLION)
TABLE 431 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR VACCINES, BY TYPE, 2019–2022 (USD MILLION)
TABLE 432 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET
FOR VACCINES, BY TYPE, 2023–2029 (USD MILLION)
TABLE 433 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2019–2022 (USD MILLION)
TABLE 434 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY DISEASE INDICATION, 2023–2029 (USD MILLION)
TABLE 435 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2019–2022 (USD MILLION)
TABLE 436 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET,
BY ROUTE OF ADMINISTRATION, 2023–2029 (USD MILLION)
TABLE 437 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 438 POULTRY PHARMACEUTICALS MARKET: DEGREE OF COMPETITION
TABLE 439 POULTRY PHARMACEUTICALS MARKET: REGION FOOTPRINT
TABLE 440 POULTRY PHARMACEUTICALS MARKET: ANIMAL TYPE FOOTPRINT
TABLE 441 POULTRY PHARMACEUTICALS MARKET: PRODUCT FOOTPRINT
TABLE 442 POULTRY PHARMACEUTICALS MARKET: DISEASE INDICATION FOOTPRINT
TABLE 443 POULTRY PHARMACEUTICALS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
TABLE 444 POULTRY PHARMACEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 445 POULTRY PHARMACEUTICALS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 446 POULTRY PHARMACEUTICALS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021?NOVEMBER 2024
TABLE 447 POULTRY PHARMACEUTICALS MARKET: DEALS, JANUARY 2021?NOVEMBER 2024
TABLE 448 POULTRY PHARMACEUTICALS MARKET:
EXPANSIONS, JANUARY 2021?NOVEMBER 2024
TABLE 449 POULTRY PHARMACEUTICALS MARKET:
OTHER DEVELOPMENTS, JANUARY 2021?NOVEMBER 2024
TABLE 450 MERCK ANIMAL HEALTH: COMPANY OVERVIEW
TABLE 451 MERCK ANIMAL HEALTH: PRODUCTS OFFERED
TABLE 452 ELANCO: COMPANY OVERVIEW
TABLE 453 ELANCO: PRODUCTS OFFERED
TABLE 454 ELANCO: DEALS, JANUARY 2021–NOVEMBER 2024
TABLE 455 ELANCO: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
TABLE 456 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
TABLE 457 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
TABLE 458 BOEHRINGER INGELHEIM INTERNATIONAL GMBH:
PRODUCT APPROVALS, JANUARY 2021– NOVEMBER 2024
TABLE 459 BOEHRINGER INGELHEIM INTERNATIONAL GMBH:
DEALS, JANUARY 2021– NOVEMBER 2024
TABLE 460 BOEHRINGER INGELHEIM INTERNATIONAL GMBH:
EXPANSIONS, JANUARY 2021– NOVEMBER 2024
TABLE 461 CEVA SANTE ANIMALE: COMPANY OVERVIEW
TABLE 462 CEVA SANTE ANIMALE: PRODUCTS OFFERED
TABLE 463 ZOETIS SERVICES LLC: COMPANY OVERVIEW
TABLE 464 ZOETIS SERVICES LLC: PRODUCTS OFFERED
TABLE 465 ZOETIS SERVICES LLC: JANUARY 2021–NOVEMBER 2024
TABLE 466 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
TABLE 467 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
TABLE 468 VIRBAC: COMPANY OVERVIEW
TABLE 469 VIRBAC: PRODUCTS OFFERED
TABLE 470 VIRBAC: DEALS, JANUARY 2021– NOVEMBER 2024
TABLE 471 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY OVERVIEW
TABLE 472 PHIBRO ANIMAL HEALTH CORPORATION: PRODUCTS OFFERED
TABLE 473 PHIBRO ANIMAL HEALTH CORPORATION:
DEALS, JANUARY 2021– NOVEMBER 2024
TABLE 474 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW
TABLE 475 HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED
TABLE 476 HESTER BIOSCIENCES LIMITED: DEALS, JANUARY 2021–NOVEMBER 2024
TABLE 477 MEIJI ANIMAL HEALTH CO., LTD.: COMPANY OVERVIEW
TABLE 478 MEIJI ANIMAL HEALTH CO., LTD.: PRODUCTS OFFERED
TABLE 479 VENKY’S INDIA: COMPANY OVERVIEW
TABLE 480 VENKY’S INDIA: PRODUCTS OFFERED
TABLE 481 BIMEDA CORPORATE: COMPANY OVERVIEW
TABLE 482 BIMEDA CORPORATE: PRODUCTS OFFERED
TABLE 483 CALIER: COMPANY OVERVIEW
TABLE 484 CALIER: PRODUCTS OFFERED
TABLE 485 HIPRA: COMPANY OVERVIEW
TABLE 486 HIPRA: PRODUCTS OFFERED
TABLE 487 VETANCO: COMPANY OVERVIEW
TABLE 488 VETANCO: PRODUCTS OFFERED
TABLE 489 VAXXINOVA INTERNATIONAL BV: COMPANY OVERVIEW
TABLE 490 VAXXINOVA INTERNATIONAL BV: PRODUCTS OFFERED
TABLE 491 BIOVAC GROUP: COMPANY OVERVIEW
TABLE 492 BIOVAC GROUP: PRODUCTS OFFERED
TABLE 493 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
TABLE 494 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED
TABLE 495 Î.L.KAR.-AGROZOOVET-SERVICE: COMPANY OVERVIEW
TABLE 496 Î.L.KAR.-AGROZOOVET-SERVICE: PRODUCTS OFFERED
TABLE 497 INDOVAX: COMPANY OVERVIEW
TABLE 498 INDOVAX: PRODUCTS OFFERED
TABLE 499 AVIMEX: COMPANY OVERVIEW
TABLE 500 AVIMEX: PRODUCTS OFFERED
